, Tracking Stock Market Picks
Enter Symbol:
AcelRx Pharmaceuticals Inc (ACRX) [hlAlert]

down 10.02 %

AcelRx Pharmaceuticals Inc (ACRX) rated Outperform with price target $8 by RBC Capital Mkts

Posted on: Tuesday,  Mar 10, 2015  8:25 AM ET by RBC Capital Mkts

RBC Capital Mkts rated Outperform AcelRx Pharmaceuticals Inc (NASDAQ: ACRX) on 03/10/2015, when the stock price was $4.79.
Since then, AcelRx Pharmaceuticals Inc has lost 10.02% as of 01/06/2016's recent price of $4.31.
If you would have followed this RBC Capital Mkts's recommendation on ACRX, you would have lost 10.02% of your investment in 302 days.

AcelRx Pharmaceuticals, Inc. is a development-stage company. The Company is a specialty pharmaceutical company focused on the development and commercialization of therapies for the treatment of acute and breakthrough pain. It has completed Phase 2 clinical development for two additional product candidates, the Sufentanil NanoTab BTP Management System, or ARX-02, for the treatment of cancer breakthrough pain (BTP), and the Sufentanil/Triazolam NanoTab, or ARX-03, designed to provide mild sedation, anxiety reduction and pain relief for patients undergoing painful procedures in a physician?s office. The Company is preparing to initiate two Phase 3 clinical trials for its product candidate, the Sufentanil NanoTab PCA System, or ARX-01. ARX-02 is a product candidate for the treatment of cancer patients who suffer from breakthrough pain. ARX-03 Sufentanil/Triazolam NanoTab is a single, fixed-dose sublingual product candidate.

RBC Capital Markets is an international corporate and investment bank that provides innovative solutions and a focused set of products and services to institutions, corporations, governments and high net worth clients around the world. With nearly 3,700 professional and support staff, we operate out of 75 offices in 15 countries and deliver our products and services through operations in Asia and Australasia, the UK and Europe and in every major North American city.
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
3/10/2015 8:25 AM Buy
4.79 8.00
as of 8/27/2015
1 Week down  -4.22 %
1 Month up  5.63 %
3 Months up  32.61 %
1 YTD down  -10.02 %

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy